Moshe Arditi, MD, is the executive vice chair of the Department of Pediatrics for Research and the director of the Pediatric Infectious Diseases and Immunology Division at Cedars-Sinai. He is also director of the Infectious and Immunological Diseases Research Center in the Department of the Biomedical Sciences and a member of the Cedars-Sinai Smidt Heart Institute. Arditi is the program director of the Cedars-Sinai Immunobiology T32 training grant. He and his team have been among the leaders at Cedars-Sinai to promote the concept of "team science," with five principal investigators in his group focused on translating basic science advances to patients."
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Arditi Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Domiciano TP, Wakita D, Jones HD, Crother TR, Verri WA Jr, Arditi M, Shimada K.
Sci Rep. 2017 Feb 2;7:41539.
Noval Rivas M, Lee Y, Wakita D, Chiba N, Dagvadorj J, Shimada K, Chen S, Fishbein MC, Lehman TJ, Crother TR, Arditi M.
Arthritis Rheumatol. 2017 Feb;69(2):410-421.
Burns JC, Koné-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M.
Arthritis Rheumatol. 2017 Feb;69(2):268-276.
The Infectious and Immunologic Diseases Research Center (IIDRC) is working on new ways to tackle challenging medical problems in infectious and immunologic diseases, accelerating the discovery process and commercializing new therapies. The program fosters excellence in basic and translational clinical research in infectious and immunological diseases, with a special focus on personalized medicine. The center allows a diverse community of clinicians and scientists to communicate more effectively, providing opportunities for them to collaborate on research that seeks to cure, treat or prevent a range of human infectious and immunologic diseases and conditions. The program seeks to accelerate the pace of scientific discovery, encouraging groundbreaking, interdepartmental and interdisciplinary translational research among the Medical Center’s research community. The center makes efforts to maximize technology-transfer opportunities and works to expedite commercialization of new therapies. Enhancing philanthropic support for research in this area is a key mission of the center. Communicating scientific and clinical advances to scientists, physicians, policy-makers and the general public is also a priority. The center’s areas of focus in translational research include: vascular inflammation (atherosclerosis, vasculitis, Kawasaki disease); lung infection (pneumonia, asthma, COPD, acute lung injury); transplant immunology; tumor immunology; fetal-maternal and perinatal-neonatal inflammation-infection and immunity.